Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (1y) (2013 - 2026)
Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -7.45% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -51.96% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 9,472.45% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 2.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.70% |
| Dec 31, 2025 | 1.69% |
| Sep 30, 2025 | -6.77% |
| Jun 30, 2025 | -7.19% |
| Mar 31, 2025 | -50.53% |
| Dec 31, 2024 | 10.50% |
| Sep 30, 2024 | -29.17% |
| Jun 30, 2024 | -22.29% |
| Mar 31, 2024 | 48.25% |
| Dec 31, 2023 | -65.74% |
| Sep 30, 2023 | 58.70% |
| Jun 30, 2023 | 21.55% |
| Mar 31, 2023 | 7.22% |
| Dec 31, 2022 | 60.15% |
| Sep 30, 2022 | -5.42% |
| Jun 30, 2022 | 30.26% |
| Mar 31, 2022 | -28.65% |
| Dec 31, 2021 | -4.20% |
| Sep 30, 2021 | -6.83% |
| Jun 30, 2021 | 118.35% |